By activating multiple inflammatory pathways as well as promoting the accumulation of apoptotic cells/endogenous TLR7 ligands and B-cell activation, the inducible pristane-lupus model may afford a window into the roles played by the multiple pathways shaping the widely variable phenotypes of SLE in different patients. Here, TLR7 is linked to systemic lupus erythematosus.